» Articles » PMID: 25436421

MicroRNA-520g Induces Epithelial-mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Targeting SMAD7

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2014 Dec 2
PMID 25436421
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Aberrant expression of miRNAs contributes to HCC development. Here, we observed elevated miR-520g expression in tumor samples from HCC patients with relapse and metastasis, and this high miR-520g expression was correlated with poor survival. Through gain- and loss-of-function studies, miR-520g was demonstrated to facilitate HCC cell migration, invasion and epithelial-mesenchymal transition (EMT). SMAD7 was identified as a direct target of miR-520g. Accordingly, we conclude that high miR-520g expression promotes HCC cell mobility and EMT by targeting SMAD7, and this is correlated with reduced survival in HCC patients.

Citing Articles

MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.

Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .

PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.


Expression study of microRNA cluster on chromosome 19 (C19MC) in tumor tissue and serum of breast cancer patient.

Altalebi S, Haghi M, Feizi M Mol Biol Rep. 2023; 50(12):9825-9831.

PMID: 37840066 DOI: 10.1007/s11033-023-08801-x.


A multi-omics study on cutaneous and uveal melanoma.

Zhang Q, Lin Z, Chen J, Zheng W Int J Ophthalmol. 2021; 14(1):32-41.

PMID: 33469481 PMC: 7790682. DOI: 10.18240/ijo.2021.01.05.


Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.

Jinesh G, Napoli M, Ackerman H, Raulji P, Montey N, Flores E Sci Rep. 2020; 10(1):12371.

PMID: 32704163 PMC: 7378193. DOI: 10.1038/s41598-020-69179-5.


MiR-223 inhibits the proliferation, invasion and EMT of nasopharyngeal carcinoma cells by targeting SSRP1.

Gao L, Xiong X Int J Clin Exp Pathol. 2020; 11(9):4374-4384.

PMID: 31949834 PMC: 6962943.